東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Leukocyte telomere length and lens t...

Sanders, Jason Leigh.

Linked to FindBook

Google Book

Amazon

博客來

Leukocyte telomere length and lens transparency as biomarkers in population studies of human aging.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Leukocyte telomere length and lens transparency as biomarkers in population studies of human aging./
Author:	Sanders, Jason Leigh.
Description:	190 p.
Notes:	Source: Dissertation Abstracts International, Volume: 74-01(E), Section: B.
Contained By:	Dissertation Abstracts International74-01B(E).
Subject:	Health Sciences, Aging. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3529585
ISBN:	9781267661739

Leukocyte telomere length and lens transparency as biomarkers in population studies of human aging.
Sanders, Jason Leigh.

Leukocyte telomere length and lens transparency as biomarkers in population studies of human aging. - 190 p.

Source: Dissertation Abstracts International, Volume: 74-01(E), Section: B.

Thesis (Ph.D.)--University of Pittsburgh, 2012.

Biomarkers of aging are indicators of characteristics of an organism which change over time. Validating aging biomarkers will enable researchers to better understand aging mechanisms and design interventions which promote healthy aging. This dissertation uses population-based cohorts to explore two emerging biomarkers of human aging, leukocyte telomere length (LTL) and lens transparency.

ISBN: 9781267661739Subjects--Topical Terms:

1669845
Health Sciences, Aging.

Leukocyte telomere length and lens transparency as biomarkers in population studies of human aging.
LDR:03444nam a2200325 4500 001 1968972
005 20141219110805.5
008 150210s2012 ||||||||||||||||| ||eng d
020 $a 9781267661739
035 $a (MiAaPQ)AAI3529585
035 $a AAI3529585
040 $a MiAaPQ $c MiAaPQ
100 1 $a Sanders, Jason Leigh. $3 2106214
245 1 0 $a Leukocyte telomere length and lens transparency as biomarkers in population studies of human aging.
300 $a 190 p.
500 $a Source: Dissertation Abstracts International, Volume: 74-01(E), Section: B.
500 $a Adviser: Anne B. Newman.
502 $a Thesis (Ph.D.)--University of Pittsburgh, 2012.
520 $a Biomarkers of aging are indicators of characteristics of an organism which change over time. Validating aging biomarkers will enable researchers to better understand aging mechanisms and design interventions which promote healthy aging. This dissertation uses population-based cohorts to explore two emerging biomarkers of human aging, leukocyte telomere length (LTL) and lens transparency.
520 $a Short LTL records systemic oxidation and inflammation and contributes to cellular senescence. Previous studies focused on its association with diagnosed age-related chronic disease in one physiologic system and have generated equivocal results. Because disease can be undiagnosed and exist in several tissues simultaneously, previous research may have underestimated associations with LTL. We studied the association of LTL with an index of disease burden, which tabulates age-related chronic disease in five physiologic systems regardless of diagnosis. To the extent that an index across systems might capture an underlying propensity to age-related changes in all systems, a marker of fundamental aging processes such as LTL should be associated with it. We show LTL is associated with this index of disease burden. Thus, LTL might indicate widespread incremental changes in structure or function in older adults independent of diagnosed disease.
520 $a Lens transparency may reflect systemic load of molecular glycation and denaturation, which have been associated with aging. Correlates of reduced lens transparency in humans are undefined. We studied the association of lens transparency to markers of aging and disease. We found that older adults with highly transparent lenses have longer LTL, lower prevalence of diabetes, better cognition, and lower odds of an ApoE4 allele, the strongest genetic risk factor for Alzheimer's disease. Transparency is unrelated to risk factors for atherosclerosis or noninvasively measured vascular disease.
520 $a What are the public health implications of this work? First, LTL may aid in the development of screening tools and interventions to prevent age-related disease simultaneously in multiple physiologic systems. Second, lens transparency may help detect amyloid-related brain pathology, which is vital to developing interventions to slow brain aging. Future epidemiologic research should focus on correlating changes in LTL and transparency to changes in age-related phenotypes and the ability of LTL and transparency to predict age-related outcomes.
590 $a School code: 0178.
650 4 $a Health Sciences, Aging. $3 1669845
650 4 $a Health Sciences, Public Health. $3 1017659
650 4 $a Health Sciences, Epidemiology. $3 1019544
690 $a 0493
690 $a 0573
690 $a 0766
710 2 $a University of Pittsburgh. $3 958527
773 0 $t Dissertation Abstracts International $g 74-01B(E).
790 $a 0178
791 $a Ph.D.
792 $a 2012
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3529585